Scientific discovery profoundly shapes our world, and Dr. Alea Mills leads an exceptional international team committed to breakthroughs that benefit humanity.

Her work focuses on glioblastoma, the most common and aggressive form of brain cancer, where only about 5 out of 100 people with glioblastoma are alive 5 years after they get the news from their doctors; half of these patients live for just around a year. Dr. Mills and her team identified a novel target that, when depleted, can extend survival in nearly three quarters of cases. They uncovered that a rogue protein alters chromosome packaging, silencing the body's natural cancer defenses. Crucially, they found a way to switch this defense system back on, offering hope against this deadly disease.

Dr. Mills continues to advance these findings, with the goal of improving outcomes and quality of life for those affected by glioblastoma.

Note: CSHL does not provide food so please plan ahead.

Seating is limited and is first come, first serve. Standing room is available once the seats are filled. Reserving your ticket on Eventbrite does not guarantee you a seat at the event.